Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration
Abstract
:1. Introduction
2. Current Therapeutic Options for COVID-19
3. COVID-19 Treatment after Bariatric Surgery
4. Summary of Recommendations
Author Contributions
Funding
Conflicts of Interest
References
- Azran, C.; Wolk, O.; Zur, M.; Fine-Shamir, N.; Shaked, G.; Czeiger, D.; Sebbag, G.; Kister, O.; Langguth, P.; Dahan, A. Oral drug therapy following bariatric surgery: An overview of fundamentals, literature and clinical recommendations. Obes. Rev. 2016, 17, 1050–1066. [Google Scholar] [CrossRef] [PubMed]
- McLachlan, L.A.; Chaar, B.B.; Um, I.S. Pharmacokinetic changes post-bariatric surgery: A scoping review. Obes. Rev. 2020, 21, e12988. [Google Scholar] [CrossRef] [PubMed]
- Baettig, V.; Courlet, P.; Delko, T.; Battegay, M.; Marzolini, C. Boosted darunavir, emtricitabine and tenofovir pharmacokinetics in sthe early and late postgastric bypass surgery periods. AIDS 2018, 32, 1903–1905. [Google Scholar] [CrossRef] [PubMed]
- Israel, S.; Elinav, H.; Elazary, R.; Porat, D.; Gibori, R.; Dahan, A.; Azran, C.; Horwitz, E. Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy. Antimicrob. Agents Chemother. 2020, 64. [Google Scholar] [CrossRef] [PubMed]
- Dahan, A.; Porat, D.; Azran, C.; Mualem, Y.; Sakran, N.; Abu-Abeid, S. Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: A Case Report and Review of the Literature. Obes. Surg. 2019, 29, 735–738. [Google Scholar] [CrossRef] [PubMed]
- Porat, D.; Markovic, M.; Zur, M.; Fine-Shamir, N.; Azran, C.; Shaked, G.; Czeiger, D.; Vaynshtein, J.; Replyanski, I.; Sebbag, G.; et al. Increased Paracetamol Bioavailability after Sleeve Gastrectomy: A Crossover Pre- vs. Post-Operative Clinical Trial. J. Clin. Med. 2019, 8, 1949. [Google Scholar] [CrossRef] [Green Version]
- Azran, C.; Langguth, P.; Dahan, A. Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 2017, 13, 1245–1247. [Google Scholar] [CrossRef]
- Azran, C.; Porat, D.; Fine-Shamir, N.; Hanhan, N.; Dahan, A. Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects. Surg. Obes. Relat. Dis. 2019, 15, 333–341. [Google Scholar] [CrossRef]
- Darwich, A.S.; Henderson, K.; Burgin, A.; Ward, N.; Whittam, J.; Ammori, B.J.; Ashcroft, D.M.; Rostami-Hodjegan, A. Trends in oral drug bioavailability following bariatric surgery: Examining the variable extent of impact on exposure of different drug classes. Br. J. Clin. Pharmacol. 2012, 74, 774–787. [Google Scholar] [CrossRef] [Green Version]
- Porat, D.; Dahan, A. Medication Management after Bariatric Surgery: Providing Optimal Patient Care. J. Clin. Med. 2020, 9, 1511. [Google Scholar] [CrossRef]
- Mehra, M.R.; Ruschitzka, F.; Patel, A.N. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. Lancet 2020, 395, 1820. [Google Scholar] [CrossRef]
- NIH. Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19. 2020. Available online: https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ (accessed on 31 August 2020).
- Gautret, P.; Lagier, J.-C.; Parola, P.; Hoang, V.T.; Meddeb, L.; Mailhe, M.; Doudier, B.; Courjon, J.; Giordanengo, V.; Vieira, V.E.; et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents 2020, 105949. [Google Scholar] [CrossRef] [PubMed]
- Bani-Sadr, F.; Hentzien, M.; Pascard, M.; N’Guyen, Y.; Servettaz, A.; Andreoletti, L.; Kanagaratnam, L.; Jolly, D. Corticosteroid therapy for patients with CoVID-19 pneumonia: A before-after study. Int. J. Antimicrob. Agents 2020, 106077. [Google Scholar] [CrossRef] [PubMed]
- Titanji, B.K.; Farley, M.M.; Mehta, A.; Connor-Schuler, R.; Moanna, A.; Cribbs, S.K.; O’Shea, J.; DeSilva, K.; Chan, B.; Edwards, A.; et al. Use of Baricitinib in Patients with Moderate and Severe COVID-19. Clin. Infect. Dis. 2020. [Google Scholar] [CrossRef]
- Finzi, E. Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients. Int. J. Infect. Dis. 2020. [Google Scholar] [CrossRef]
- Song, Y.; Zhang, M.; Yin, L.; Wang, K.; Zhou, Y.; Zhou, M.; Lu, Y. COVID-19 Treatment: Close to a Cure?—A Rapid Review of Pharmacotherapies for the Novel Coronavirus. Int. J. Antimicrob. Agents 2020, 106080. [Google Scholar] [CrossRef]
- Thomas, D.E.; Lyons, J.S.; Greene, B.S.; Petri, M.A. Low hydroxychloroquine blood levels in patients who have had gastric bypass surgery. Lupus Sci. Med. 2019, 6, e000335. [Google Scholar] [CrossRef] [Green Version]
- Padwal, R.S.; Ben-Eltriki, M.; Wang, X.; Langkaas, L.-A.; Sharma, A.M.; Birch, D.W.; Karmali, S.; Brocks, D.R. Effect of gastric bypass surgery on azithromycin oral bioavailability. J. Antimicrob. Chemother. 2012, 67, 2203–2206. [Google Scholar] [CrossRef] [Green Version]
- Woods, C.P.; Corrigan, M.; Gathercole, L.; Taylor, A.; Hughes, B.; Gaoatswe, G.; Manolopoulos, K.; Hogan, A.E.; O’Connell, J.; Stewart, P.M.; et al. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT). J. Clin. Endocrinol. Metab. 2015, 100, 1434–1444. [Google Scholar] [CrossRef]
- Humpert, P.M.; Samigullin, A.; Lindner, A.; Weihrauch, J.; Oikonomou, D.; Metzner, C.; Bottcher, K.A.; Morcos, M. Impaired dexamethasone resorption in two patients with pseudo-Cushing after bariatric surgery: Implications for immunosuppressive treatment. Clin. Obes. 2020, e12383. [Google Scholar] [CrossRef]
- Stein, J.; Stier, C.; Raab, H.; Weiner, R. Review article: The nutritional and pharmacological consequences of obesity surgery. Aliment. Pharmacol. Ther. 2014, 40, 582–609. [Google Scholar] [CrossRef] [PubMed]
- Ruz, M.; Carrasco, F.; Rojas, P.; Codoceo, J.; Inostroza, J.; Basfi-fer, K.; Csendes, A.; Papapietro, K.; Pizarro, F.; Olivares, M.; et al. Zinc absorption and zinc status are reduced after Roux-en-Y gastric bypass: A randomized study using 2 supplements. Am. J. Clin. Nutr. 2011, 94, 1004–1011. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krebs, N.F. Overview of zinc absorption and excretion in the human gastrointestinal tract. J. Nutr. 2000, 130, 1374S–1377S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Michalik, D.E.; Jackson-Alvarez, J.T.; Flores, R.; Tolentino-Baldridge, C.; Batra, J.S. Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass. J. Int. Assoc. Provid. AIDS Care 2015, 14, 116–119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- MacBrayne, C.E.; Blum, J.D.; Kiser, J.J. Tenofovir, Emtricitabine, and Darunavir/Ritonavir Pharmacokinetics in an HIV-Infected Patient After Roux-en-Y Gastric Bypass Surgery. Ann. Pharmacother. 2014, 48, 816–819. [Google Scholar] [CrossRef]
- Boffito, M.; Lucchini, A.; Maiello, A.; Dal Conte, I.; Hoggard, P.G.; Back, D.J.; Di Perri, G. Lopinavir/ritonavir absorption in a gastrectomized patient. AIDS 2003, 17, 136–137. [Google Scholar] [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Azran, C.; Porat, D.; Dahan, A.; Dicker, D. Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration. J. Clin. Med. 2020, 9, 2827. https://doi.org/10.3390/jcm9092827
Azran C, Porat D, Dahan A, Dicker D. Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration. Journal of Clinical Medicine. 2020; 9(9):2827. https://doi.org/10.3390/jcm9092827
Chicago/Turabian StyleAzran, Carmil, Daniel Porat, Arik Dahan, and Dror Dicker. 2020. "Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration" Journal of Clinical Medicine 9, no. 9: 2827. https://doi.org/10.3390/jcm9092827